$UTHR as a result of the Court’s decision, United Therapeutics believes that it is entitled to an order instructing the FDA to withdraw approval of $LQDA's NDA for Yutrepia.
It also intends to seek monetary damages for past infringement, which could include a royalty on past sales of Yutrepia.
$LLY oral GLP-1 Foundayo demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study. $NVO $VKTX